Intensive management versus standard care in early psoriatic arthritis
Phase 4
Completed
- Conditions
- Topic: MusculoskeletalSubtopic: Musculoskeletal (all Subtopics)Disease: MusculoskeletalMusculoskeletal DiseasesPsoriatic and enteropathic arthropathies
- Registration Number
- ISRCTN30147736
- Lead Sponsor
- niversity of Leeds (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 118
Inclusion Criteria
1. Consultant diagnosis of psoriatic arthritis (PsA)
2. Disease duration less than 24 months
3. Active disease
4. Aged over 18 years, either sex
5. Able to consent
Exclusion Criteria
1. Previous treatment with disease modifying anti-rheumatic drugs (DMARDs) for PsA
2. Under the age of 18 years
3. Pregnant women or planning pregnancy
4. Recent use of investigational drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of study patients achieving an ACR 20 response at 12 months
- Secondary Outcome Measures
Name Time Method Changes in clinical response over 6 and 12 months